Drug-induced endocrine disorders in the intensive care unit
The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
Abstract
The neuroendocrine response to critical illness is key to the maintenance of homeostasis. Many of the drugs administered routinely in the intensive care unit significantly impact the neuroendocrine system. These agents can disrupt the hypothalamic-pituitary-adrenal axis, cause thyroid abnormalities, and result in dysglycemia. Herein, we review major drug-induced endocrine disorders and highlight some of the controversies that remain in this area. We also discuss some of the more rare drug-induced syndromes that have been described in the intensive care unit. Drugs that may result in an intensive care unit admission secondary to an endocrine-related adverse event are also included. Unfortunately, very few studies have systematically addressed drug-induced endocrine disorders in the critically ill. Timely identification and appropriate management of drug-induced endocrine adverse events may potentially improve outcomes in the critically ill. However, more research is needed to fully understand the impact of medications on endocrine function in the intensive care unit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, it is important to keep in mind that some medications (eg, high doses of heparins, phenobarbital, opioids, and etomidate) used in the ICU may adversely impact endocrine function or may alter the accuracy of laboratory testing (152, 153).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [152]
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Several medical ICU-based studies (141) in fact showed harm from IIT, ostensibly related to insulin-induced hypoglycemia.”
BackgroundOpioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Malmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560 · cited 1×
“The Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study (191) created initial enthusiasm, as the authors observed marked improvements in short- and long-term outcome among myocardial infarction patients in whom insulin infusions were provided in hospital, and reasonable glycemic c…”
ResultPerioperative Total Parenteral Nutrition in Surgical Patients
(1991) · New England Journal of Medicine · doi:10.1056/nejm199108223250801 · Cited by 1,256
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170 · cited 2×
“Others (139, 142) concluded that some level of hyperglycemia may be adaptive, despite widespread acknowledgment that marked hyperglycemia is maladaptive.”
BackgroundSelf-citationGriesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Self-citationAnnane, D. (2000) · JAMA · doi:10.1001/jama.283.8.1038 · Cited by 1,000 · cited 1×
“As such, the development of insulin-induced hypoglycemia may be simply a marker of poor physiologic reserve, similar to the poor prognosis associated with lack of adrenocortical function in ICU patients (11, 139).”
Background
Research works printed but not linked: 19
- Fragen, 1983, Lancet, 2, 625
- Bromberg, 1995, J Am Coll Surg, 180, 532
- Francois Venter, 2006, S Afr Med J, 96, 62
- Beadsworth, 2008, Int J Tuberc Lung Dis, 12, 314
- Meya, 2007, Afr Health Sci, 7, 101
- Boidin, 1985, Acta Anaesthesiol Belg, 3, 15
- Boidin, 1986, Eur J Anaesthesiol, 3, 417
- Gheno, 2002, Ann Ital Med Int, 17, 51
- Ng, 2006, Hong Kong Med J, 12, 254
- Sirota, 1992, Mt Sinai J Med, 59, 79
- Martino, 2001, Endocr Rev, 22, 240
- Piga, 2008, Minerva Endocrinol, 33, 213
- Samuels, 1997, J Clin Endocrinol Metab, 82, 3700
- Migneco, 2005, Eur Rev Pharmacol Sci, 9, 69
- Ramaswamy, 2005, J Psychiatry Neurosci, 30, 57
- Fitzgerald, 1984, J Trop Med Hyg, 87, 15
- Gupta, 2001, J Assoc Physicians India, 49, 426
- Raschke, 1991, Arch Intern Med, 15, 591, 10.1001/archinte.1991.00400030121022 · doi:10.1001/archinte.1991.00400030121022 · Paper page
- Inzucchi, 2003, Diabetes, 52, A96
Cited by
Lithium: A review of pharmacology, clinical uses, and toxicity
Oruch, R., Elderbi, M. A., Khattab, H. A., Pryme, I. F., & Lund, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.042 · Cited by 221
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Stress Hyperglycemia in Pediatric Critical Illness: The Intensive Care Unit Adds to the Stress!
Srinivasan, V. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600106 · Cited by 61
Ultrasound dilution: An accurate means of determining cardiac output in children*
Crittendon, I., Dreyer, W. J., Decker, J. A., & Kim, J. J. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182196804 · Cited by 50
Critical Illness–Related Corticosteroid Insufficiency in Small Animals
Martin, L. G. (2011) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2011.03.021 · Cited by 46
Metadata
- Authors
- Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Brigham and Women's Hospital (US)
- Venue
- Critical Care Medicine
- Published
- 2010-06
- Volume
- 38
- Issue
- 6 Suppl
- Pages
- S219-S230
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2049265346
- Cited by
- 30
- References
- 196
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 3
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Keywords
- drug-induced endocrine disorders, intensive care unit, hypothalamic-pituitary-adrenal axis, thyroid dysfunction, dysglycemia, critically ill patients
- MeSH terms
- Amiodarone, Anti-Arrhythmia Agents, Antifungal Agents, Critical Care, Cytochrome P-450 Enzyme System, Dopamine, Endocrine System Diseases, Etomidate, Glucocorticoids, Humans, Hyperglycemia, Hypnotics and Sedatives, Insulin, Intensive Care Units, Lithium, Pancreatic Diseases, Pituitary-Adrenal System, Thyroid Diseases, United States, Antimanic Agents, Drug-Related Side Effects and Adverse Reactions, Cytochrome P-450 Enzyme Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug-induced endocrine disorders in the intensive care unit. https://app.cochat.ai/papers/10.1097/ccm.0b013e3181dda0f2
- The paper
- Thomas, Z., Bandali, F., McCowen, K., & Malhotra, A. (2010). Drug-induced endocrine disorders in the intensive care unit. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e3181dda0f2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.